Latest filing published 21 Dec 2018 for ENDOCYTE INC, €605k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John C. Aplin: trading record in brief
John C. Aplin is a declared insider of Endocyte Inc, with filings sourced from SEC (Form 4). Over a trading history stretching from 9 February 2011 to 21 December 2018, the count stands at 9 filings.
Purchases make up the whole of the open-market record (1 purchase, €50k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants.
The record was last updated on 21 December 2018 with a transaction (€605k) in Endocyte Inc. The latest purchase dates back some time: it was published 5,442 days ago, on 16 December 2011. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John C. Aplin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 28,863 shares@ US$24.0089.7% of flowCommon StockSEC:0001104659-18-074349:0
- 3,300 shares@ US$24.0010.3% of flowCommon StockSEC:0001104659-18-074349:1
- 3,300 shares0Common StockSEC:0001179110-18-006319:0
- 3,300 shares0Common StockSEC:0001179110-17-006715:0
- 2,250 shares0Common StockSEC:0001179110-16-024067:0
- 2,250 shares0Common StockSEC:0001144204-15-032013:0
- 20,000 shares@ US$3.27Common StockSEC:0001209191-11-061815:0Canonical exit: 15 Mar 2012 (T+90)
- 288,235 sharesCommon StockSEC:0001209191-11-008943:0
- 143,895 sharesCommon StockSEC:0001209191-11-008943:1
9 of 9 declarations